Skip to main content
. 2020 Jul 22;3(9):e201900619. doi: 10.26508/lsa.201900619

Figure 5. CaMKK2 is a novel BH4-binding target.

Figure 5.

(A, B, C, D, E, F) Protein–ligand docking simulation results for BH4–CaMKIV (A, B) and BH4–CaMKK2 (D, E). (C, F) Sensorgrams for BH4 binding to recombinant CaMKIV (C) or CaMKK2 (F).